factual
Personalized cancer drug could cost $10 million under current FDA
If each personalized pancreatic cancer therapy had to pass the current FDA process as an individual product, each would cost about $10 million, and the KJ Muldoon bespoke therapy cost about $8 million and is useful only to him.
factualpending
Speaker
Jeff CollerEvidence Quote
“That cancer therapy would be a $10 million therapy if we had to go through the current FDA for pancreatic cancer because each one of those drugs would be an individualized product”
Created: 11/17/2026, 7:10:08 AM
Your notes
Loading notes...